Imunon has reported new immunogenicity and safety data from its proof-of-concept Phase I trial’s ongoing analyses of the IMNN-101 DNA plasmid vaccine. The investigational vaccine, based on the company ...

One avenue for new vaccine development is mucosal vaccines. In theory, dosing the vaccine directly into the respiratory tract ...

Results of IMNN-101 Proof-of-Concept study demonstrate persistent immunogenicity in trial participants and further validate PlaCCine® ...

As the industry moves towards a more integrated and diversified vaccine ecosystem, GeoVax’s MVA-based vaccines should provide a scalable, durable, and globally accessible solution that enhances the ...

President Donald Trump’s pick to lead the National Institutes of Health answered sharp questions in a confirmation hearing ...

When Health and Human Services Sec. Robert F. Kennedy Jr. Kennedy answered questions during the first cabinet meeting of the ...

One hundred forty-six measles cases have been reported in the outbreak in West Texas, the Texas Department of Health Services ...

As a measles outbreak causes dozens of illnesses in West Texas, it’s important to know how to identify signs of the illness – especially in young children. Measles, one of the world’s most ...